Merck said Wednesday it had licensed an experimental GLP-1 obesity pill from a Chinese drugmaker ... and Novo Nordisk’s dominance in the weight-loss market. It also comes amid worries that ...
Hosted on MSN1mon
Merck’s weight-loss pill deal: what it means for Eli LillyThe said agreement wins it rights to HS-10535 – an experimental weight-loss pill (oral) developed by the Chinese drugmaker. Hansoh will receive an upfront payment of $112 million from Merck and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback